Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
GBI Research has released its latest research “Lifestyle Disorders Market to 2016 – Limited Pipeline Products and Slow Progress in R&D are Major Concerns”, which essentially provides insights on lifestyle disorders therapeutics sales and price forecasts until 2016. The report also examines the global lifestyle disorders therapies treatment usage patterns. In addition, the geographical distribution of lifestyle disorders therapies across the US, the top five countries in the European region and Japan are also provided in the report. The report...
View full press release